Trademark Search in Canada

GP PHARM

View On IC.GC.CA

REGISTERED

on 9 Sept 2024

Last Applicant/ Owned by

GP PHARM S.A.

Polígono Industrial Els.Vinyets-Els Fogars,2 Carretera C-244 Km. 22E-08777 SANT QUINTÍ DE MEDIONA, Barcelona

Serial Number

2157627 filed on 13^th Dec 2021

Registration Number

TMA1254841 registered on 9^th Sept 2024

Registration expiry Date

24^th Apr 2027

Correspondent Address

ROBIC AGENCE PI S.E.C./ ROBIC IP AGENCY LP

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

H3B1S6

GP PHARM

Trademark usage description

chemicals used in the cosmetics and pharmaceutical industries for human use, namely, chemical preparations for use in the manufacture of cosmetics and Read More

Vienna Information

26 . 1 . 1

CirclesCercles

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

Classification Information

Class [001]
Chemicals used in the cosmetics and pharmaceutical industries for human use, namely, chemical preparations for use in the manufacture of cosmetics and pharmaceuticals.

Classification kind code

Class [005]
Pharmaceutical preparations other than veterinary preparations, namely, pharmaceutical preparations for use in urology, pharmaceutical preparations for the treatment of gynaecological disease and disorders, pharmaceutical preparations for use in oncology, pharmaceuticals for use in cardiology, pharmaceutical preparations for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies, pharmaceutical preparations for use in gastroenterology, pharmaceutical preparations for use in endocrinology, pharmaceutical preparations for immunology, pharmaceutical preparations for rheumatology, pharmaceutical preparations the diagnosis and treatment of disorders relating to sexual reproduction and fertility, pharmaceutical preparations for gynaecological treatments, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for use in chemotherapy, pharmaceutical preparations for hormone therapies, pharmaceutical preparations for treatment of pain, pharmaceutical preparations for treatment of muscular disorders and treatment of metabolic disorders namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy and anemia, pharmaceutical preparations containing active proteins and peptides for medical use, pharmaceutical and biological preparations for medical use, namely, for use in oncology, hematology and in tissue and organ transplantation; Pharmaceutical preparations other than veterinary preparations, namely, pharmaceutical creams that facilitate the topical administration of pharmaceuticals for the treatment of dermatological conditions being dermatitis, eczema and psoriasis, pharmaceutical preparations and substances for the treatment of diabetes, pharmaceutical preparations and substances for the treatment of gastrointestinal diseases, pharmaceutical preparations for diagnosing and treating neurodegenerative diseases; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, pharmaceutical preparations for human use that modulate the immune system, pharmaceutical preparations for ophthalmological use, pharmaceutical preparations for prevention and treatment of ocular disorders and diseases. pharmaceutical preparations for reducing cholesterol, pharmaceutical preparations for regulating the immune system, pharmaceutical preparations for the prevention and treatment of cardiovascular diseases, pharmaceutical preparations for the prevention and treatment of lysosomal storage diseases, pharmaceutical preparations for the relief of pain, pharmaceutical preparations for the treatment of arthritis, pharmaceutical preparations for the treatment of autoimmune diseases, pharmaceutical preparations for the treatment of hormonal disorders, pharmaceutical preparations for the treatment of hypercholesteremia, pharmaceutical preparations for the treatment of hiperlipidemia, pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders, pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders, pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases, pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders, pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, pharmaceutical preparations for the treatment of musculoskeletal disorders, pharmaceutical preparations for the treatment of myalgia and neuralgia, pharmaceutical preparations for the treatment of obesity, pharmaceutical preparations for the treatment of oncological diseases and disorders, pharmaceutical preparations for the treatment of ophthalmic conditions, pharmaceutical preparations for the treatment of ophthalmological diseases and disorders, pharmaceutical preparations for the treatment of osteoporosis, pharmaceutical preparations for treating allergies, pharmaceutical preparations for use in ophthalmology, pharmaceutical preparations for use in the treatment of autoinflammatory diseases, pharmaceutical preparations for use in the treatment of immunological disorders, pharmaceutical preparations for use in the treatment of musculoskeletal diseases, pharmaceutical preparations for use in tissue and organ transplantation, pharmaceutical preparations namely, anti-inflammatories, pharmaceuticals for the treatment of bone diseases, human pharmaceuticals for treatment of prostate cancer, pharmaceutical preparations for the treatment of erectile dysfunction, pharmaceutical preparations for the treatment of alopecia and androgenic alopecia, pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone, androgen and estrogen disorders, pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction, pharmaceutical preparations for treating malignant tumors, pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, Crohn's disease, irritable bowel syndrome, pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders namely irritable bowel disorders and symptoms and pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; sanitary products for medical purposes, namely, sanitary preparations for medical purposes for the treatment of autoimmune diseases, specifically psoriasis, arthritis and Crohn's disease; dietetic substances for medical use for the prevention and treatment of gastrointestinal diseases and disorders, food for babies; plasters, as material for dressings; material for dental fillings and dental impressions; all-purpose disinfectants; disinfectants for medical apparatus and instruments; herbicides; pharmaceutical preparations and substances for use in urology, oncology and gynecology.

Classification kind code

Class [042]
Scientific and technological services, as well as research and design services relating thereto namely scientific research for medical purposes in the field of urology, oncology, gynecology cardiology, neurology, gastroenterology, endocrinology, immunology, rheumatology, ophthalmology, biotechnology, anti-cancer treatments, chemotherapy, hormonal therapies, treatment of pain and inflammation, treatment of muscular disorders and treatment of metabolic disorders ; pharmaceutical research services; biological therapeutic research services, clinical research in the field of urology, oncology, gynecology cardiology, neurology, gastroenterology, endocrinology, immunology, rheumatology, ophthalmology, biotechnology, anti-cancer treatments, chemotherapy, hormonal therapies, treatment of pain and inflammation, treatment of muscular disorders and treatment of metabolic disorders and medical research.

Classification kind code

Mark Details

Serial Number

2157627

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 9^th Nov 2023	Agent Changed
Submitted for opposition 22 on 11^th Apr 2023	Search Recorded
Submitted for opposition 20 on 11^th Apr 2023	Examiner's First Report
Submitted for opposition 223 on 11^th Apr 2023	Total Provisional Refusal
Submitted for opposition 256 on 31^st Oct 2022	Notification of Possible Opposition Sent
Submitted for opposition 257 on 30^th Dec 2021	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 30^th Dec 2021	Created
Submitted for opposition 31 on 30^th Dec 2021	Formalized
Submitted for opposition 30 on 13^th Dec 2021	Filed
Submitted for opposition 228 on 24^th Apr 2017	International Registration

GP PHARM

Classification Information

Class [001]Chemicals used in the cosmetics and pharmaceutical industries for human use, namely, chemical preparations for use in the manufacture of cosmetics and pharmaceuticals.

Classification kind code

Classification kind code

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [001]
Chemicals used in the cosmetics and pharmaceutical industries for human use, namely, chemical preparations for use in the manufacture of cosmetics and pharmaceuticals.